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Background: Mental stress has been shown to provoke myocardial ischemia in a significant proportion of patients with stable coronary artery 
disease (CAD). Mental stress-induced myocardial ischemia (MSI) is a poor prognostic factor and is linked to fatal and non-fatal cardiac events in 
CAD patients. The mechanisms underlying this phenomenon and the therapeutic approaches to combat it are still unclear. Arguably, treatment of MSI 
could reduce morbidity and mortality in CAD patients. Preclinical and clinical data have shown the role of angiotensin II in the physiologic response 
to stress, but its role in MSI has not yet been explored. The purpose of this study was to evaluate the effect of Angiotensin-Converting Enzyme (ACE) 
inhibitors or Angiotensin Receptor Blockers (ARBs) on MSI in patients with stable CAD.
Methods: Post-hoc analysis of 218 patients (149 men, 69 women, 110 taking ACE inhibitors, 29 taking ARBs) with a documented history of CAD 
was performed. Mental stress was induced via a public speaking task. Myocardial perfusion imaging with 99m-Tc-sestamibi was used for rest and 
stress images. Images were analyzed for number and severity of perfusion defects. The summed difference score (SDS) based on the difference 
between summed stress and rest perfusion scores was used. Ischemia was defined as an SDS of ≥4. 
Results: The unadjusted odds ratio of developing MSI comparing patients on or off ACE inhibitors was 0.46 [95% CI: (0.23, 0.94)]. The odds 
ratio was 0.423 [95% CI: (0.197, 0.906)] after adjusting for age, sex, hypertension, diabetes, left ventricular dysfunction, renal dysfunction, 
antidepressants, and beta blockers. Among subjects taking ACE inhibitors, there was no statistically significant difference in blood pressure and heart 
rate responses to mental stress in relation to MSI outcome. The unadjusted and adjusted odds ratio comparing patients on or off ARBs were 1.87 
[95% CI: (0.76, 4.59)] and 1.76 [95% CI: (0.671, 4.619)], respectively.
Conclusions: ACE inhibitor therapy was associated with a reduction of the odds of developing MSI by about 58%. This significant reduction was 
independent of any hemodynamic changes expected with ACE inhibitor therapy. ARBs did not show a protective effect.
